Cargando…

A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients

Objectives: To assess whether the histopathological features of the synovium before starting treatment with the TNFi certolizumab-pegol could predict clinical outcome and examine the modulation of histopathology by treatment. Methods: Thirty-seven RA patients fulfilling UK NICE guidelines for biolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nerviani, Alessandra, Di Cicco, Maria, Mahto, Arti, Lliso-Ribera, Gloria, Rivellese, Felice, Thorborn, Georgina, Hands, Rebecca, Bellan, Mattia, Mauro, Daniele, Boutet, Marie-Astrid, Giorli, Giovanni, Lewis, Myles, Kelly, Stephen, Bombardieri, Michele, Humby, Frances, Pitzalis, Costantino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214807/ https://www.ncbi.nlm.nih.gov/pubmed/32431716 http://dx.doi.org/10.3389/fimmu.2020.00845

Ejemplares similares

Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response
por: Boutet, Marie-Astrid, et al.
Publicado: (2021)

B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure
por: Rivellese, F., et al.
Publicado: (2020)

Follicular dendritic cell differentiation is associated with distinct synovial pathotype signatures in rheumatoid arthritis
por: El Shikh, Mohey Eldin M., et al.
Publicado: (2022)

Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
por: Lliso-Ribera, Gloria, et al.
Publicado: (2019)

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
por: Rivellese, Felice, et al.
Publicado: (2022)

Angiogenic gene expression and vascular density are reflected in ultrasonographic features of synovitis in early rheumatoid arthritis: an observational study
por: Kelly, Stephen, et al.
Publicado: (2015)

Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis
por: Boutet, Marie-Astrid, et al.
Publicado: (2020)

Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?
por: Humby, Frances Claire, et al.
Publicado: (2017)

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
por: Humby, Frances, et al.
Publicado: (2021)

Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis
por: Micheroli, Raphael, et al.
Publicado: (2022)

Ectopic Lymphoid Structures: Powerhouse of Autoimmunity
por: Corsiero, Elisa, et al.
Publicado: (2016)

IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential
por: Boutet, Marie-Astrid, et al.
Publicado: (2019)

IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors
por: Nerviani, Alessandra, et al.
Publicado: (2021)

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018)

Persistence of Mast Cell-Positive Synovitis in Early Rheumatoid Arthritis Following Treatment With Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs
por: Rivellese, Felice, et al.
Publicado: (2020)

Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis
por: Gomez, Esteban A., et al.
Publicado: (2020)

Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer
por: Nerviani, Alessandra, et al.
Publicado: (2018)

Characterization of a Synovial B Cell–Derived Recombinant Monoclonal Antibody Targeting Stromal Calreticulin in the Rheumatoid Joints
por: Corsiero, Elisa, et al.
Publicado: (2018)

Network analysis of synovial RNA sequencing identifies gene-gene interactions predictive of response in rheumatoid arthritis
por: Sciacca, Elisabetta, et al.
Publicado: (2022)

Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure
por: Scirè, Carlo Alberto, et al.
Publicado: (2007)

Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
por: Humby, Frances, et al.
Publicado: (2019)

Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs
por: Corsiero, Elisa, et al.
Publicado: (2016)

Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus
por: Rivellese, Felice, et al.
Publicado: (2021)

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
por: Pagani, Sara, et al.
Publicado: (2020)

Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
por: Humby, Frances, et al.
Publicado: (2009)

Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
por: Ferrari, Mathieu, et al.
Publicado: (2021)

Accumulation of Self-Reactive Naïve and Memory B Cell Reveals Sequential Defects in B Cell Tolerance Checkpoints in Sjögren’s Syndrome
por: Corsiero, Elisa, et al.
Publicado: (2014)

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide
por: Wythe, Sarah E, et al.
Publicado: (2013)

Isolated pauci-immune pulmonary capillaritis
por: Mehrotra, Ashok Kumar, et al.
Publicado: (2015)

Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter
por: Whitehead, Maria A., et al.
Publicado: (2012)

Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis
por: Jones, Gareth W., et al.
Publicado: (2015)

CXCL13, CCL21 and CXCL12 are upregulated in mucosal-associated lymphoid tissue lymphomas in patients with Sjorgen's syndrome and cooperate in the maintenance of the immune response and malignant cell survival
por: Barone, F, et al.
Publicado: (2007)

An Unusual Presentation of Pauci-Immune Necrotizing Glomerulonephritis
por: Talon, Andrew, et al.
Publicado: (2020)

Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes
por: Lewis, Myles J., et al.
Publicado: (2019)

Synovial Tissue Sampling in Rheumatological Practice—Past Developments and Future Perspectives
por: Humby, Frances C.
Publicado: (2019)

Mast Cells in Early Rheumatoid Arthritis
por: Rivellese, Felice, et al.
Publicado: (2019)

Editorial: Synovial pathobiology and pathogenesis of inflammatory arthritis
por: Small, Annabelle, et al.
Publicado: (2022)

Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4(+) T Cell Metabolic Rewiring
por: Pucino, Valentina, et al.
Publicado: (2019)

ANCA negative pauci-immune glomerulonephritis with systemic involvement
por: Sampathkumar, K., et al.
Publicado: (2010)

ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment
por: Izzedine, Hassane, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_buhm61giu7u90gnfnvq8vrf98u